Pharmagreen Provides Significant Scientific Development Updates

— Pharmagreen Biotech, Inc. (PHBI), a company specializing in the development of high quality tissue cultured starter plantlets for the cannabis and hemp industry, is pleased to provide a scientific development update. Since December 2019 the company’s strategic research and development partner, Botanical Research In Motion Inc. (B.R.I.M.), has continued very successful growing trials withContinue reading “Pharmagreen Provides Significant Scientific Development Updates”

WeedMD Partners with CannTx Life Sciences to Enhance Genetics Bank of New Cultivars and Preserve its Elite Proprietary Cannabis Strains

University of Guelph-affiliated company to provide WeedMD with innovative tissue cultured-plant services via Steadystem Solutions for cloning accuracy and plant asset preservation — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, announced today it has partnered with Guelph-based CannTx Life Sciences Inc. (“CannTx”) to add new cultivars to its geneticsContinue reading “WeedMD Partners with CannTx Life Sciences to Enhance Genetics Bank of New Cultivars and Preserve its Elite Proprietary Cannabis Strains”

WeedMD Cultivars Included in UHN-led Chronic Pain Study

Company’s products on ‘Medical Cannabis by Shoppers’ platform, registered under blockchain-enabled program added to University Health Network’s research trials — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it is one of the first licensed producers (LP) to have its products and strains included in theContinue reading “WeedMD Cultivars Included in UHN-led Chronic Pain Study”

Zenabis Provides Corporate Update

VANCOUVER, BC, June 16, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) today provided a corporate update on its recent activities. Highlights Zenabis Atholville has commenced cultivation of thirteen new high THC cultivars with commercial roll out of three of the new cultivars expected to occur in July with the remaining ones to be rolledContinue reading “Zenabis Provides Corporate Update”

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agriculture (“ICA”). Blueberries hasContinue reading “Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners”